Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.87−0.50 (-9.31%)
Close on Nov 13, 2026Market cap $306.04MP/E –Yield –
Cytosorbents total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cytosorbents's total debt was $17.24M at Jun 30, 2026. For fiscal 2025 it was $16.67M, up 19.1% from the year before. The highest annual figure on record is $16.67M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.67M | +19.1% |
| FY2024 | Dec 31, 2024 | $14.00M | +177.5% |
| FY2023 | Dec 31, 2023 | $5.04M | +0.9% |
| FY2022 | Dec 31, 2022 | $5.00M | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $15.05M | +51.4% |
| FY2018 | Dec 31, 2018 | $9.94M | -0.5% |
| FY2017 | Dec 31, 2017 | $9.99M | +103.4% |
| FY2016 | Dec 31, 2016 | $4.91M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.24M | +19.9% |
| Q1 FY2026 | Mar 31, 2026 | $16.96M | +19.5% |
| Q4 FY2025 | Dec 31, 2025 | $16.67M | +19.1% |
| Q3 FY2025 | Sep 30, 2025 | $14.57M | +5.5% |
| Q2 FY2025 | Jun 30, 2025 | $14.38M | +5.1% |
| Q1 FY2025 | Mar 31, 2025 | $14.19M | +220.3% |
| Q4 FY2024 | Dec 31, 2024 | $14.00M | +177.5% |
| Q3 FY2024 | Sep 30, 2024 | $13.81M | +174.4% |
| Q2 FY2024 | Jun 30, 2024 | $13.67M | +172.3% |
| Q1 FY2024 | Mar 31, 2024 | $4.43M | -11.4% |
| Q4 FY2023 | Dec 31, 2023 | $5.04M | – |
| Q3 FY2023 | Sep 30, 2023 | $5.03M | -66.8% |
| Q2 FY2023 | Jun 30, 2023 | $5.02M | -66.8% |
| Q4 FY2022 | Dec 31, 2022 | $5.00M | -66.9% |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $15.16M | +1.0% |
| Q2 FY2020 | Jun 30, 2020 | $15.12M | +51.4% |
| Q1 FY2020 | Mar 31, 2020 | $15.09M | +51.4% |
| Q4 FY2019 | Dec 31, 2019 | $15.05M | +51.4% |
| Q3 FY2019 | Sep 30, 2019 | $15.02M | +51.4% |
| Q2 FY2019 | Jun 30, 2019 | $9.99M | +1.0% |
| Q1 FY2019 | Mar 31, 2019 | $9.96M | +1.0% |
| Q4 FY2018 | Dec 31, 2018 | $9.94M | -0.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.92M | -0.5% |
| Q2 FY2018 | Jun 30, 2018 | $9.89M | -0.5% |
| Q1 FY2018 | Mar 31, 2018 | $9.87M | +100.3% |
| Q4 FY2017 | Dec 31, 2017 | $9.99M | +103.4% |
| Q3 FY2017 | Sep 30, 2017 | $9.97M | +103.5% |
| Q2 FY2017 | Jun 30, 2017 | $9.94M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.91M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.90M | – |
See a number that looks wrong?